Optimizing the management of hepatobiliary neoplasms: a multidisciplinary and molecular challenge

Por Kadakia, Kunal C., Hwang, Jimmy J.
Publicado no J Gastrointest Oncol (2017)

Immuno‐Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD‐L1 Testing May Not Be Enough

Por Weinberg, Benjamin A., Xiu, Joanne, Hwang, Jimmy J., Shields, Anthony F., Salem, Mohamed E., Marshall, John L.
Publicado no Oncologist (2018)

Maintenance Therapy With Capecitabine in Patients With Resected Pancreatic Adenocarcinoma After Adjuvant Therapy: A Retrospective Cohort Study

Por Weinberg, Benjamin A., Wang, Hongkun, Yang, Xuezhong, Wu, Christina S., Pishvaian, Michael J., He, Aiwu R., Marshall, John L., Hwang, Jimmy J.
Publicado em 2014

Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma

Por Hwang, Jimmy J., Kuruvilla, John, Mendelson, David, Pishvaian, Michael J., Deeken, J.F., Siu, Lillian L., Berger, Mark S., Viallet, Jean, Marshall, John L.
Publicado em 2010

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers

Por Salem, Mohamed E., Weinberg, Benjamin A., Xiu, Joanne, El-Deiry, Wafik S., Hwang, Jimmy J., Gatalica, Zoran, Philip, Philip A., Shields, Anthony F., Lenz, Heinz-Josef, Marshall, John L.
Publicado no Oncotarget (2017)

Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer

Por TIAN, XUEFEI, SHIVAPURKAR, NARAYAN, WU, ZHENG, HWANG, JIMMY J., PISHVAIAN, MICHAEL J., WEINER, LOUIS M., LEY, LISA, ZHOU, DAN, ZHI, XIULING, WELLSTEIN, ANTON, MARSHALL, JOHN L., HE, AIWU RUTH
Publicado no Oncol Lett (2016)

A phase II study of the PARP Inhibitor, veliparib plus temozolomide in patients with heavily pretreated, metastatic colorectal cancer

Por Pishvaian, Michael J., Slack, Rebecca S, Jiang, Wei, He, A. Ruth, Hwang, Jimmy J., Hankin, Amy, Dorsch-Vogel, Karen, Kukadiya, Divyesh, Weiner, Louis M., Marshall, John L, Brody, Jonathan R.
Publicado no Cancer (2018)

Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors

Por Kunz, Pamela L., He, Aiwu R., Colevas, A. Dimitrios, Pishvaian, Michael J., Hwang, Jimmy J., Clemens, Pamela L., Messina, Marianne, Kaleta, Remigiusz, Abrahao, Fernanda, Sikic, Branimir I., Marshall, John L.
Publicado em 2012

Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets

Por Weinberg, Benjamin A., Xiu, Joanne, Lindberg, Michael R., Shields, Anthony F., Hwang, Jimmy J., Poorman, Kelsey, Salem, Mohamed E., Pishvaian, Michael J., Holcombe, Randall F., Marshall, John L., Morse, Michael A.
Publicado no J Gastrointest Oncol (2019)

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

Por Salem, Mohamed E., Puccini, Alberto, Grothey, Axel, Raghavan, Derek, Goldberg, Richard M., Xiu, Joanne, Korn, W. Michael, Weinberg, Benjamin A., Hwang, Jimmy J., Shields, Anthony F., Marshall, John L., Philip, Philip A., Lenz, Heinz-Josef
Publicado no Mol Cancer Res (2018)

A Phase 1 Study of Efatutazone, an Oral Peroxisome Proliferator-Activated Receptor Gamma Agonist, Administered to Patients With Advanced Malignancies

Por Pishvaian, Michael J., Marshall, John L., Wagner, Andrew J., Hwang, Jimmy J., Malik, Shakun, Cotarla, Ion, Deeken, John F., He, A. Ruth, Daniel, Hirut, Halim, Abdel-Baset, Zahir, Hamim, Copigneaux, Catherine, Liu, Kejian, Beckman, Robert A., Demetri, George D.
Publicado em 2012

The Challenge of Measuring Intra-Individual Change in Fatigue during Cancer Treatment

Por Moinpour, Carol M., Donaldson, Gary W., Davis, Kimberly M., Potosky, Arnold L., Jensen, Roxanne E., Gralow, Julie R., Back, Anthony L., Hwang, Jimmy J., Yoon, Jihye, Bernard, Debra L., Loeffler, Deena R., Rothrock, Nan E., Hays, Ron D., Reeve, Bryce B., Smith, Ashley Wilder, Hahn, Elizabeth A., Cella, David
Publicado no Qual Life Res (2016)

Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer

Por Tokunaga, Ryuma, Xiu, Joanne, Johnston, Curtis, Goldberg, Richard M., Philip, Philip A., Seeber, Andreas, Naseem, Madiha, Lo, Jae Ho, Arai, Hiroyuki, Battaglin, Francesca, Puccini, Alberto, Berger, Martin D., Soni, Shivani, Zhang, Wu, Hwang, Jimmy J., Shields, Anthony F., Marshall, John L., Baba, Hideo, Korn, W. Michael, Lenz, Heinz-Josef
Publicado no Clin Cancer Res (2019)

Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma

Por Stein, Matthew K., Williard, Forrest W., Xiu, Joanne, Tsao, Miriam W., Martin, Michael G., Deschner, Benjamin W., Dickson, Paxton V., Glazer, Evan S., Yakoub, Danny, Shibata, David, Grothey, Axel F., Philip, Philip A., Hwang, Jimmy J., Shields, Anthony F., Marshall, John L., Korn, W. Michael, Lenz, Heinz-Josef, Deneve, Jeremiah L.
Publicado no J Surg Oncol (2020)